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This mini-review focuses on lipid modulation of BK (MaxiK, BKCa) current by a direct
interaction between lipid and the BK subunits and/or their immediate lipid environment.
Direct lipid-BK protein interactions have been proposed for fatty and epoxyeicosatrienoic
acids, phosphoinositides and cholesterol, evidence for such action being less clear for
other lipids. BK α (slo1) subunits are sufficient to support current perturbation by fatty
and epoxyeicosatrienoic acids, glycerophospholipids and cholesterol, while distinct BK
β subunits seem necessary for current modulation by most steroids. Subunit domains
or amino acids that participate in lipid action have been identified in a few cases: hslo1
Y318, cerebral artery smooth muscle (cbv1) R334,K335,K336, cbv1 seven cytosolic CRAC
domains, slo1 STREX and β1 T169,L172,L173 for docosahexaenoic acid, PIP2, cholesterol,
sulfatides, and cholane steroids, respectively. Whether these protein motifs directly bind
lipids or rather transmit the energy of lipid binding to other areas and trigger protein
conformation change remains unresolved. The impact of direct lipid-BK interaction on
physiology is briefly discussed.
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Large conductance, Ca2+/voltage-gated K+ (BK, maxiK, slo1)
channels result from tetrameric association of α (slo1) subunits
(Figure 1). Inmost tissues, slo1 channels are associated with small
accessory proteins termed β subunits. Four types of β subunits
have been identified, their expression being tissue-specific (Orio
et al., 2002). This mini-review focuses on lipid modulation of BK
current observed in cell-free systems and thus, studies support-
ing direct interactions between lipid and BK proteins and/or their
immediate proteo-lipid environment.
FATTY ACIDS
Increase in BK channel activity by low μM FA has been reported
in VSM (Kirber et al., 1992; Ahn et al., 1994; Dopico et al.,
1994; Clarke et al., 2002, 2003; Martín et al., 2013) and GH3
cells (Denson et al., 2000), and following channel expression in
HEK293 cells (Hoshi et al., 2013a-c) and Xenopus oocytes (Sun
et al., 2007). FA-induced BK activation occurs at a wide range of
[Ca2+]i, and [Mg2+]i (Ahn et al., 1994), and in virtual absence
of Ca2+i (Clarke et al., 2002; Hoshi et al., 2013b). Moreover, FAs
neither require voltage-sensor activation (Hoshi et al., 2013b) nor
alter the slope of the activity-voltage relationship (Denson et al.,
Abbreviations: AA, arachidonic acid; BK, calcium- and voltage-gated, large
conductance potassium; cAMP, cyclic adenosine monophosphate; Ca2+i , intra-
cellular calcium; CB, cannabinoid; CHO, Chinese hamster ovary cells; CLR,
cholesterol; CRAC, cholesterol recognition amino acid consensus; CTD, cytoso-
lic tail domain; DHA, docosahexaenoic acid; DHET, 11,12-dihydroxyeicosatrienoic
acid; EET, epoxyeicosatrienoic acid; EETe, epoxyeicosatetraenoic acid; FA, fatty
acid; HEK, human embryonic kidney; GH3, rat pituitary tumor epithelial-like
cells; HCN-1A, human cortical neuronal cells; HENA, 3-hydroxyolean-12-en-
30-oate; I/O, inside-out patch; LPI, lysophosphatidylinositol; LT, leukotriene;
PC, phosphatidylcholine; PG, prostaglandins; PI, phosphoinositide; PIP2, phos-
phatidylinositol 4,5-bisphosphate; PK, protein kinase; Po, open probability; RCK,
regulator of conductance for potassium; SM, smooth muscle; SPL, sphingolipid;
TM, transmembrane; TxA2, thromboxane A2; VSM, vascular smooth muscle.
2000). In particular, DHA favors channel dwelling in conducting
states by destabilizing the closed conformation of the pore (Hoshi
et al., 2013a,b).
FA-induced BK activation does not correlate with changes in
membrane fluidity or production of free radicals and oxygen
metabolites (Denson et al., 2000). In addition, FA action per-
sists in cell-free, membrane patches (Denson et al., 2000; Clarke
et al., 2002; Hoshi et al., 2013b). The membrane-impermeable
arachidonoyl-CoA potentiates current only when applied to the
cytosolic side of the membrane patch (Denson et al., 2000; Sun
et al., 2008), suggesting that the FA-recognition site(s) is accessi-
ble from the inner membrane leaflet.
Presence of a negatively charged head-group seems critical for
FA “direct” action on BK channels. This action, however, per-
sists after screening membrane surface charge with high-ionic
strength solution (Clarke et al., 2002). Structure-activity studies
reveal that unsaturated FAs (DHA, arachidonic, and oleic acids)
enhance steady-state amplitude and slow inactivation of hslo1+β2
currents whereas saturated FAs fail to do so (Sun et al., 2007).
Cis-unsaturated FAs increase GH3 cell BK current whereas sat-
urated or trans-unsaturated FAs have no effect (Denson et al.,
2000). On the other hand, long-chain FAs are more effective
than short-chain counterparts in activating VSM BK channels
(Ahn et al., 1994; Clarke et al., 2002). The mechanisms and tar-
gets underlying differential modulation of BK currents by FA of
variant structure remain unidentified.
Channel subunit composition plays a critical role in the
final effect of FA on BK current. In the same expression sys-
tem, DHA potentiates and fails to alter hslo1-mediated and
dslo1-mediated current, respectively (Hoshi et al., 2013c). These
findings are consistent with the existence of specific, DHA-
recognizing sites in slo1 proteins, with hslo1 Y318 playing a
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FIGURE 1 | Lipid-sensing areas in a BK heterodimer made of α (slo1)
and β1 subunits. The cartoon highlights protein regions in which mutations
ablate lipid sensitivity of BK channels in cell-free systems, such as excised
membrane patches or planar lipid bilayers. Whether these regions directly
bind lipids or allosterically modulate BK channel function upon lipid binding
to other BK areas remains unresolved.
critical role in DHA-sensing (Hoshi et al., 2013c). In addition,
DHA potentiation of hslo1 current is amplified by BK β1 and
β4 subunits (Hoshi et al., 2013a). On the other hand, AA slows
inactivation and potentiates current mediated by β2- or β3-
containing BK channels. In contrast, long-chain acyl-CoAs facil-
itate hslo2+β2 inactivation and thus, inhibit overall current (Sun
et al., 2008). The presence of opposite charge on residues at posi-
tions 11 (N-terminus) and 18 in BK β transmembrane domain-1
(TM1) is crucial for DHA action in presence of β1 and β4 (Hoshi
et al., 2013a). It remains unclear whether these residues represent
an FA binding site or transduce FA-docking energy into gating
modification. Consistent with modulatory or “allosteric” mecha-
nisms, AA inactivates α+β2-mediated currents but fails to affect
inactivation of current by the β2-inactivating ball peptide alone,
suggesting that AA does not interact with the ball peptide itself
(Sun et al., 2007).
The physiological and pathophysiological consequences of BK
channel modulation by FAs are under investigation. AA elimi-
nates a transient K+ current in neocortical neurons (Sun et al.,
2007), which should drastically alter excitability. BK currents
mediate AA-induced relaxation of pulmonary artery, yet the exact
contribution of a direct FA-BK interaction to this AA action
remains unclear (Guerard et al., 2004). However, omega-3 FAs
lower blood pressure by directly activating BK channels in VSM
(Hoshi et al., 2013b).
PROSTANOIDS
PGI2, PGE2, unoprostone and AH13205 activate BK currents in
retinal pericytes (Burnette and White, 2006), coronary artery SM
(Zhu et al., 2002), HCN-1A (Cuppoletti et al., 2007) and tra-
becular meshwork cells (Stumpff et al., 2005), respectively. In
contrast, U46619 inhibits BK current when the channel is co-
expressed with thromboxane A2(TxA2) receptors in HEK293 cells
(Li et al., 2013). PGI2- and PGE2-induced BK activation require
cAMP-stimulated cross-activation of PKG, but not PKA (Hata
et al., 2000; Zhu et al., 2002). In VSM, however, PGI2 activation of
BK current involves a cAMP-independent, Gs protein-dependent
component (Tanaka et al., 2004). In turn, U46619 inhibits chan-
nel activity in cell-free patches, an action that involves indepen-
dent associations between channel-forming subunits, BK β1, and
TxA2 receptors. A direct interaction between prostanoids and BK
subunits, however, remains unclear.
Prostanoid-induced BK activationmay contribute to the relax-
ant activity of PGE2 in trabecular meshworks (Wang et al., 1998;
Stumpff et al., 2005), and PGI2-induced VSM relaxation (Tanaka
et al., 2004) with consequent retinal vasodilation and blood flow
augmentation (Hata et al., 2000). Prostanoid-BK interactions
may provide a basis for using PGI2-mimetics against pulmonary
hypertension (Benyahia et al., 2013). Such interactions may
also underlie unoprostone-induced hyperpolarization and con-
sequent protection of cortical neurons against glutamate-induced
Ca2+i dysregulation (Cuppoletti et al., 2007).
EPOXYEICOSATRIENOIC ACIDS AND LEUKOTRIENES
EET and derivatives activate BK channels in VSM (Wu et al., 2000;
Zhang et al., 2001; Lauterbach et al., 2002; Archer et al., 2003;
Dimitropoulou et al., 2007; Loot et al., 2012) and non-vascular
SM (Benoit et al., 2001), cortical collecting duct (Sun et al., 2009),
pituitary GH3 (Wu et al., 2000), HEK293 (Fukao et al., 2001),
and adrenal chromaffin cells (Twitchell et al., 1997), and crude
airway SM microsomes reconstituted into lipid bilayers (Benoit
et al., 2001). EET-related epoxyeicosatetraenoic acids (EETe) and
5-oxo-eicosatetraenoic acid potentiate BK current in human pul-
monary artery and distal bronchi (Morin et al., 2007, 2009), and
cerebral and mesenteric VSM (Hercule et al., 2007). EET and
EETe effective concentrations range from nM to low μM (Wu
et al., 2000; Benoit et al., 2001; Lauterbach et al., 2002; Hercule
et al., 2007; Morin et al., 2009).
EET increases BK current without affecting unitary conduc-
tance (Wu et al., 2000; Benoit et al., 2001; Fukao et al., 2001).
Rather, EET and 11,12-dihydroxyeicosatrienoic acid (DHET)
increase channel open probability (Po) by lengthening open
and shortening closed times (Wu et al., 2000; Lu et al.,
2001). Modification of gating by EET and EETe is observed
across a wide voltage range (Wu et al., 2000; Lauterbach
et al., 2002; Hercule et al., 2007) and unaffected by strong
buffering of Ca2+i (Benoit et al., 2001; Hercule et al., 2007).
However, DHET fails to activate BK channels in absence of
Ca2+i (Lu et al., 2001). EET-induced BK channel activation is
suppressed by anti-Gαs antibody (Fukao et al., 2001), and by
protein phosphatase 2A inhibitor (Dimitropoulou et al., 2007).
However, EET-induced BK activation could be observed in cell-
free patches (Wu et al., 2000; Dimitropoulou et al., 2007)
and following channel reconstitution into artificial lipid bilay-
ers (Benoit et al., 2001). EET-induced activation of recom-
binant channels expressed in HEK293 cells does not require
β1 subunits (Fukao et al., 2001). Consistently, EETe action
on BK channels is preserved in cerebral and mesenteric VSM
lacking BK β1 subunits (Hercule et al., 2007). Collectively,
these findings point at the BK β1 subunit and its lipid
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microenvironment as the primary target of EETs and related
compounds.
It is noteworthy that 11,12-EET but neither 8,9- nor 14,15-
EET, activates BK channels in cortical collecting duct cells (Sun
et al., 2009). However, 14,15-EET activates BK channels in inside-
out patches from GH3 cells (Wu et al., 2000). In addition, while
equipotent in activating coronary artery SM BK channels, several
DHETs show a reduced efficacy when compared to 11,12-EET (Lu
et al., 2001). Structural specificity in EET action on BK chan-
nels is consistent with involvement of distinct EET-recognizing
protein sites. In contrast, data from coronary microvessel SM cell-
free membrane patches demonstrate a low structural specificity
for EET action, as several EET regioisomers and enantiomers,
epoxyeicosaquatraenoic, and epoxydocosatetraenoic acids acti-
vate BK channels with similar potencies and efficacies (Zhang
et al., 2001).
In airway SM, 20-hydroxyeicosatetraenoic acid (20-HETE)
and EETs cause membrane hyperpolarization and relaxation of
human distal bronchi (Morin et al., 2007, 2009). Likewise, EET-
induced BK activation leads to hyperpolarization and dilation
of internal mammary (Archer et al., 2003), pulmonary (Morin
et al., 2007) and mesenteric arteries (Dimitropoulou et al., 2007).
However, EET-mediated SM dilation may be counteracted by
EET-stimulated physical association of BK α and β1 subunits in
mitochondria: this association enhances mitochondria BK func-
tion, leading to loss of mitochondrial membrane potential and
thus, depolarization, as reported in pulmonary VSM (Loot et al.,
2012). Consistently, EETs fail to hyperpolarize the membrane and
relax isolated internal carotid artery (Chataigneau et al., 1998).
Finally, BK activation by EET plays an important role in flow-
stimulated K+ secretion in the cortical collecting duct (Sun et al.,
2009), and possibly in regulating adreno-chromaffin cell secretion
(Twitchell et al., 1997).
LTA4, LTB4, LTC4, LTD4, and LTE4 (nM-μM) have been
tested on β1 subunit-containing recombinant BK channels in
Xenopus oocyte I/O patches, with only LTB4 significantly increas-
ing channel activity (Bukiya and Dopico, 2013a). This finding
raises the hypothesis that BK activation via LTB4-BK interac-
tion reduces LT receptor-mediated, SM contraction by LTB4
(Rosenblum, 1985; Lawson et al., 1986; Peters-Golden and
Henderson, 2007).
CANNABINOIDS
BK channel activation by cannabinoids was detected in myome-
trial strips (Houlihan et al., 2010), trabecular meshwork cells
(Stumpff et al., 2005), ophthalmic artery (Romano and Lograno,
2006), coronary (White et al., 2001) and aortic SM (Sade et al.,
2006), and HEK293 cells expressing BK α, α+β1 or α+β4 sub-
units (Sade et al., 2006; Godlewski et al., 2009). In contrast,
μM methanandamide decreases BK activity in mesenteric and
aortic SM (Bol et al., 2012). Likewise, virodhamine and syn-
thetic analogs inhibit slo1 channels expressed in HEK293 cells
(Godlewski et al., 2009).
The differential effects of cannabinoids on BK activity raised
speculation on involvement of several mechanisms and molec-
ular entities in cannabinoid action on BK channels. However,
cannabinoid activation of SM BK channels involves neither
CB1 or CB2 receptors (White et al., 2001; Romano and
Lograno, 2006) nor cannabinoid metabolites (White et al.,
2001). Moreover, studies in HEK293 cells rule out involve-
ment of G-proteins and protein kinases (Sade et al., 2006),
leading to the hypothesis that a direct cannabinoid-BK chan-
nel interaction mediates cannabinoid-induced channel activa-
tion (Godlewski et al., 2009). However, methanandamide fails
to activate BK channels in cell-free medium (Sade et al., 2006;
Godlewski et al., 2009), suggesting that cannabinoid action
requires cellular signaling. This signal(s) would likely interact
on the slo1 protein, as cannabinoid-induced BK activation is
observed in homomeric slo1 (Sade et al., 2006; Godlewski et al.,
2009). Interestingly, cannabinoid-induced potentiation of slo1
current is lost after membrane CLR depletion and restored
upon CLR repletion (Godlewski et al., 2009), with the slo1
CTD providing several CLR-recognition domains that medi-
ate CLR modulation of slo1 activity (Singh et al., 2012) (see
below).
Cannabinoid-induced BK activation seems to play a role
in endothelium-dependent vasodilation (White et al., 2001;
Romano and Lograno, 2006; Godlewski et al., 2009), modulation
of ocular outflow (Stumpff et al., 2005), and myometrial quies-
cence (Houlihan et al., 2010). In addition, BK activation might
contribute to cannabinoid-induced neuroprotection; in particu-
lar, to cannabidiol-induced protections against pentylenetetrazol-
induced seizure (Shirazi-zand et al., 2013).
GLYCEROPHOSPHOLIPIDS
Glycerophospholipid actions on BK function have been exten-
sively studied in artificial lipid bilayers. Glycerophospholipid-
induced changes in unitary conductance (Crowley et al., 2005)
and Po (Chang et al., 1995; Crowley et al., 2005; Yuan et al.,
2007) have been reported. Increase in slo1 conductance is linked
to net negative charge in the glycerophospholipid headgroup
(Crowley et al., 2005). In turn, data from bilayers made of vari-
ant PCs show that Po decreases with increase in bilayer thickness
from PC14:1 to PC 22:1 while increasing from PC22:1 to PC24:1
(Yuan et al., 2007). While this dual profile of Po change is par-
alleled by changes in mean closed times, BK mean open time
increases monotonically with bilayer thickness (Yuan et al., 2007).
Moreover, increased open times have been linked to an increase in
the glycerophospholipid headgroup cross-sectional area (Chang
et al., 1995).
The mechanisms underlying glycerophospholipid-induced
modification of BK open and closed times and thus, Po,
remain unknown. Putative mechanisms include modification in
the physical properties of the lipid microenvironment of the
slo1 protein (Chang et al., 1995; Crowley et al., 2005; Yuan
et al., 2007); changes in lateral stress imposed by the increas-
ing headgroup size (Chang et al., 1995), perturbation of surface
charge density and distribution by negatively charged head-
groups (Moczydlowski et al., 1985), and hydrophobic mismatch
between protein and bilayer thickness (Yuan et al., 2007). Specific
glycerophospholipid-slo1 protein binding cannot be ruled out
(Crowley et al., 2005), and gains increasing acceptance as evidence
documenting direct binding of membrane lipids to transmem-
brane proteins keeps growing (Yeagle, 2014).
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PHOSPHOINOSITIDES
PI-induced BK activation has been reported in cerebral
artery and skeletal muscle myocytes (Vaithianathan et al.,
2008), and with recombinant channels expressed in Xenopus
oocytes (Vaithianathan et al., 2008; Tang et al., 2014).
Phosphatidylinositol 4,5-bisphosphate (PIP2)-induced BK activa-
tion is independent of PIP2 metabolites, and occurs in absence of
changes in unitary conductance or voltage-gating. However, this
PIP2 action requires Ca
2+
i . Moreover, PIP2 facilitates Ca
2+
i -driven
gating (Vaithianathan et al., 2008). Very recent work points at the
KDRDD loop in the slo1 RCK1 domain as mediator of functional
coupling between PIP2- and Ca
2+
i -regulation of channel activity
(Tang et al., 2014): in absence of Ca2+i , the slo1 RCK1 KDRDD
loop decreases the channel’s affinity for PIP2 whereas in presence
of Ca2+i the inhibitory modulation of such loop on PIP2 affinity
is relieved by Ca2+-D367 coordination (Tang et al., 2014).
PI-induced BK activation increases with increase in negative
charge within the PI headgroup. On the other hand, the more
water-soluble analogues diC4 and diC8 are ∼10-fold less effec-
tive than PIP2 in increasing BK activity, a difference that can be
explained by their lower affinity to a site(s) and/or by their poor
partitioning in the lipid membrane. If membrane partitioning
is required for PI to access its site of action, this site should be
located in the TM or the intracellular region of the protein, as
lipids were more effective when applied to the intracellular side
of the membrane. Indeed, the triplet R334,K335,K336 located
after S6 in the BK channel-forming cbv1 subunit CTD has been
identified as the PI-sensor (Vaithianathan et al., 2008). PIP2-
induced BK activation is observed in homomeric cbv1 channels
and drastically amplified by β1 subunits. Whether this amplifi-
cation involves PIP2-recognition sites in β1 or distinct coupling
between β1 and PIP2-bound cbv1 is under investigation.
Manipulation of endogenous PIP2 levels leads to endothelium-
independent, BK-mediated cerebral artery dilation, which sug-
gests that VSM PIP2 regulates myogenic tone via BK activation
(Vaithianathan et al., 2008).
LYSOPHOSPHOLIPIDS
In I/O patches from an umbilical vein-derived, endothelial cell
line, LPI increases BK Po at sub-μM Ca2+i and following low
basal (pre-LPI) activity while decreasing Po at μM Ca2+i and
following high basal activity. LPI has no effect in the absence
of Ca2+i (Bondarenko et al., 2011). The structural bases of LPI-
BK interaction and its dependence on Ca2+i remain unknown.
The gating modifications, however, seem complex, as LPI effect
results from changes in both open and closed time distributions.
Modulation of BK current by endogenous LPI could play a role
in the potentiation of endothelial cell hyperpolarization by low
histamine concentrations (Bondarenko et al., 2011).
SPHINGOLIPIDS (SPLs)
Sub-μM to low μM SPLs and their metabolites modulate BK
activity in pinealocytes (Chik et al., 2001), CHO cells (Chi and Qi,
2006) and an endothelial cell line (Kim et al., 2006). Sulphatides,
cerebroside termitomycesphin-A and sphingosine-1-phosphate
increase BK current (Chik et al., 2001; Chi and Qi, 2006; Kim
et al., 2006; Xu et al., 2011) while ceramides reduce current via
a PKC-dependent pathway (Chik et al., 2001).
SPL-induced BK current potentiation is dose-dependent,
reversible (Kim et al., 2006), and occurs in absence of unitary
conductance modification (Xu et al., 2011). SPL action is inde-
pendent of Ca2+i and G protein-coupled receptors (Chi and Qi,
2006; Kim et al., 2006; Xu et al., 2011). Moreover, deletion of the
STREX insert in the slo1 CTD reduces channel activation by sul-
phatides (Chi and Qi, 2006) and totally suppresses the channel’s
sensitivity to termitomycesphin-A (Xu et al., 2011).
SPL modulation of BK activity could play a role in Ca2+ mobi-
lization in endothelial cells (Kim et al., 2006), circadian regulation
(Chik et al., 2001), and neuroprotection (Chi and Qi, 2006; Xu
et al., 2011).
CHOLESTEROL, OTHER STEROIDS, AND VITAMIN D
A comprehensive and recent review on modulation of BK
channels by CLR and related cholestanes is provided elsewhere
(Dopico et al., 2012a,b). In brief, excessive membrane CLR usu-
ally decreases BK current, which has been attributed to direct
and indirect mechanisms. For decades, CLR action on BK activity
has been primarily linked to modification in membrane physical
properties by CLR insertion (Chang et al., 1995; Crowley et al.,
2003; Lundbaek, 2008). Direct CLR-BK interactions via seven
CLR-recognition amino acid consensus (CRAC)motifs in the slo1
CTD were proposed (Singh et al., 2012).
In most cases, bile acids and related cholanes, pregnanes,
androstanes, and estranes increase BK current, with eventual
modification of physiology (reviewed in Dopico et al., 2012a).
Later work identified a cholane-recognition site in the BK
β1 TM2 where cholane docks via hydrogen bonding between
its hydroxyl and T169, as well as via van der Waals interac-
tions between the steroidal rings and L172,L173 (Bukiya et al.,
2011). This site accommodates non-steroidal compounds, such
as sodium 3-hydroxyolean-12-en-30-oate (HENA). Cholane and
HENA recognition results in endothelium-independent, cerebral
artery dilation via BK activation (Bukiya et al., 2013b). Because
the identified site is found in the SM-abundant β1 and not in
other BK βs (2-4), such a site represents an attractive target for
rationale design of agents to counteract SM enhanced contrac-
tion, as found in asthma, cerebral vasospasm, systemic hyperten-
sion, erectile, bladder and uterine dysfunction (Patil et al., 2008;
Bukiya et al., 2012).
Considering: 1-the critical roles of both vitamin D and BK
channel function in maintaining healthy blood pressure levels
(Holtzclaw et al., 2011; Basit, 2013), and 2-the structural sim-
ilarity of vitamin D with the cholane lithocholic acid, which
activates BK channels (see above), it was hypothesized that vita-
min D increased BK activity. Indeed, μM vitamin D3 and 25-OH
vitamin D3 increase β1-containing, BK-mediated currents after
expression in Xenopus oocytes (Bukiya et al., unpublished). The
consequences of vitamin D action on BK currents are under
investigation.
CONCLUSIONS
Modulation of BK current by direct (e.g., independent of cell
integrity, signaling or lipid metabolism) interaction between lipid
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ligand and BK subunits has been reported for a wide variety of
lipid species. For some lipids (e.g., cholesterol), lipid-BK channel-
forming (slo1) subunit interaction accounts for most of the lipid
effect. The majority of lipid-sensing regions in slo1 have been
mapped to its intracellular tail domain. Whether these regions
directly bind lipids or modulate BK channel function following
lipid binding to other slo1 areas remains to be determined. For
other lipids (e.g., cholanes), accessory β subunits are necessary
for lipid action. Still for others (e.g., PIP2), slo1 subunits suf-
fice for lipid action, yet β subunits drastically modify the lipid’s
final effect. In most cases, the impact of direct BK channel-lipid
interaction on organ function is under investigation.
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